[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Grizzle et al., 1998 - Google Patents

Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia

Grizzle et al., 1998

Document ID
9796716668757619308
Author
Grizzle W
Myers R
Manne U
Stockard C
Harkins L
Srivastava S
Publication year
Publication venue
Tumor Marker Protocols

External Links

Snippet

Archival paraffin blocks frequently are studied to evaluate the expression of biomarkers in tumors and disease states. The identification of biomarkers is becoming increasingly important to identify and characterize early preinvasive neoplastic lesions (1–3), and to …
Continue reading at link.springer.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Shi et al. Antigen retrieval immunohistochemistry: past, present, and future
Grizzle et al. Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia
Jackson et al. Immunohistochemical techniques
Sanderson et al. Immunohistochemical and 19 immunofluorescent techniques
Taylor et al. Techniques of immunohistochemistry: principles, pitfalls, and standardization
Stumptner et al. The impact of crosslinking and non-crosslinking fixatives on antigen retrieval and immunohistochemistry
Goldstein et al. Immunohistochemistry
KR20200128689A (en) MAGEA4 detection method
Intartaglia et al. Immunohistochemistry for cancer stem cells detection: Principles and methods
AU2016248882B2 (en) Thermochemical-based antibody inactivation methods and systems
US20120003664A1 (en) Method for evaluating pre-treatment
Hayat Factors affecting antigen retrieval
Serrero et al. Immunohistochemical detection of progranulin (PGRN/GP88/GEP) in tumor tissues as a cancer prognostic biomarker
Stockard et al. Factors Affecting lmmunohistochemical Evaluation of Biomarker Expression in Neoplasia
Pal et al. Immunohistochemistry
Itaya et al. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity
Joshi et al. Molecular biologic substaging of stage I NSCLC through immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue
Kaufmann et al. Immunohistochemical differentiation of metastases of renal carcinomas versus other carcinomas with anti‐γGT monoclonal antibody 138H11
Pertschuk Immunocytochemistry for steroid receptors
Nielsen Stain Quality Management and Biomarker Analysis
Singh et al. Immunohistochemistry, A Golden Technique for Disease Diagnosis: A Review
Bratthauer The peroxidase-antiperoxidase (PAP) method and other all-immunologic detection methods
Leonardo et al. Pitfalls in Immunocytochemistry
Class Anti-Cytokeratin 5&6
Shi et al. Use of monoclonal antibodies in immunohistochemistry